↓ Skip to main content
What is this page? Embed badge

Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer

Overview of attention for article published in Clinical Cancer Research, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
twitter
34 X users

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
75 Mendeley
Summary News X Dimensions citations
So far, Dimensions has found 89 publications that cite this research output.

89

The most recent citing publications are shown below. View all 89 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.